Highlight Capital
102
36M
84
10.20
26
0.17
5
- Areas of investment
Summary
Highlight Capital appeared to be the VC, which was created in 2014. The main department of described VC is located in the Nanjin. The company was established in Asia in China.
The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Highlight Capital, startups are often financed by WI Harper Group, Qiming Venture Partners, Prometheus Capital. The meaningful sponsors for the fund in investment in the same round are Wu Capital, V Star Capital, Sequoia Capital China. In the next rounds fund is usually obtained by Aphelion Capital, Wu Capital, SDIC Fund Management.
The fund has specific favorite in a number of founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Among the most popular portfolio startups of the fund, we may highlight Chemclin, Quyi Network, Imago BioSciences. We can highlight the next thriving fund investment areas, such as Biotechnology, Biopharma. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.
The usual things for fund are deals in the range of 10 - 50 millions dollars. Speaking about the real fund results, this VC is 19 percentage points more often commits exit comparing to other organizations. The top activity for fund was in 2018. Despite it in 2019 the fund had an activity. Comparing to the other companies, this Highlight Capital performs on 26 percentage points less the average number of lead investments. The higher amount of exits for fund were in 2013. The fund is generally included in 2-6 deals every year.
Investments analytics
Analytics
- Total investments
- 102
- Lead investments
- 26
- Exits
- 5
- Rounds per year
- 10.20
- Follow on index
- 0.17
- Investments by industry
- Health Care (58)
- Biotechnology (34)
- Medical (27)
- Pharmaceutical (24)
- Biopharma (16) Show 66 more
- Investments by region
-
- China (92)
- United States (6)
- Portugal (1)
- Indonesia (1)
- Peak activity year
- 2018
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Avg. valuation at time of investment
- 20M
- Group Appearance index
- 0.88
- Avg. company exit year
- 14
- Strategy success index
- 0.40
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Tripod Preclinical Research Laboratories | 12 Apr 2023 | Pharmaceutical, Biopharma | Late Stage Venture | 5M | Nanjing, Jiangsu, China |
| Wuxi Gongwang | 10 May 2024 | Seed | Jiangsu, Wuxi Shi, China |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.